Integra LifeSciences Holdings Corporation
IART
$13.09
$0.030.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 402.06M | 415.61M | 382.65M | 442.65M | 380.83M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 402.06M | 415.61M | 382.65M | 442.65M | 380.83M |
| Cost of Revenue | 172.23M | 186.41M | 167.51M | 176.80M | 162.79M |
| Gross Profit | 229.84M | 229.19M | 215.15M | 265.84M | 218.04M |
| SG&A Expenses | 166.94M | 171.06M | 159.55M | 172.92M | 164.94M |
| Depreciation & Amortization | 3.73M | 3.75M | 3.70M | 3.72M | 3.76M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 362.17M | 382.93M | 351.17M | 378.33M | 355.71M |
| Operating Income | 39.89M | 32.67M | 31.48M | 64.32M | 25.13M |
| Income Before Tax | -6.82M | -530.95M | -30.04M | 22.54M | -20.36M |
| Income Tax Expenses | -1.42M | -46.88M | -4.74M | 3.11M | -9.67M |
| Earnings from Continuing Operations | -5.40M | -484.07M | -25.29M | 19.44M | -10.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.40M | -484.07M | -25.29M | 19.44M | -10.70M |
| EBIT | 39.89M | 32.67M | 31.48M | 64.32M | 25.13M |
| EBITDA | 78.41M | 70.37M | 68.67M | 109.01M | 61.09M |
| EPS Basic | -0.07 | -6.31 | -0.33 | 0.25 | -0.14 |
| Normalized Basic EPS | 0.18 | 0.13 | 0.15 | 0.40 | 0.11 |
| EPS Diluted | -0.07 | -6.31 | -0.33 | 0.25 | -0.14 |
| Normalized Diluted EPS | 0.18 | 0.13 | 0.15 | 0.40 | 0.11 |
| Average Basic Shares Outstanding | 76.75M | 76.70M | 76.46M | 76.42M | 76.45M |
| Average Diluted Shares Outstanding | 76.75M | 76.70M | 76.46M | 76.42M | 76.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |